Flora Peyvandi / X
Jun 26, 2025, 12:53
Flora Peyvandi: Chinese Researchers Smoothly Enter the Gene‑Therapy Arena as the Fight for Hemophilia B Heats Up
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, posted on X:
”First Chinese HB gene therapy: ISTH2025”
They say it’s better to prevent than treat—so naturally, ISTH 2025 turned into a gene‑therapy playground for Hemophilia B.
The clinical gene sessions are serving up some seriously insightful management intel!
Stay updated on the latest breakthroughs in Hematology: Hemostasis Today.
-
Mar 12, 2026, 12:05Kent H: The Lymphatic System – The Unsung Hero of Detox
-
Mar 12, 2026, 11:55Akinchan Bhardwaj: Exercise Biological Modifier of Vascular Trajectory
-
Mar 12, 2026, 11:50Guy Young: Clinical Conversations on Gene Therapy Progress in Hemophilia B at THSNA 2026
-
Mar 12, 2026, 11:44Yves Bikorimana: Causes, Diagnosis, and Management of Neonatal Alloimmune Thrombocytopenia
-
Mar 12, 2026, 11:33Kymentie Ferdinande: New Insights Into Platelet Function and Thrombus Formation in Cirrhosis
-
Mar 12, 2026, 11:17Tareq Abadl: Why Do Some People Bruise And Bleed So Easily?
-
Mar 12, 2026, 11:15Matthew Flick: The Interplay of the Fibrinogen αC-Region, Hypofibrinogenemia, and GPVI in Arterial Thrombosis
-
Mar 12, 2026, 11:08Stephen Twumasi: The Impact of Hepatitis B Infection on the Coagulation System During Pregnancy
-
Mar 12, 2026, 11:05Robert Lufkin: One Minute of Wisdom from Robert Lustig on Cholesterol, Sugar, and Heart Disease